MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)-Reference-Cited by-同舟云学术

MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)

Published:2022-01 Issue:1 Volume:22 Page:e59-e64
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

de Wild Sabine R.,Simons Janine M.,Vrancken Peeters Marie-Jeanne T.F.D.,Smidt Marjolein L.,Koppert Linetta B.

Funder

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection;Ashikaga;J Surg Oncol,2010

2. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial;Krag;Lancet Oncol,2007

3. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial;Krag;Lancet Oncol,2010

4. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial;Donker;Lancet Oncol,2014

5. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial;Galimberti;Lancet Oncol,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy – A two center cohort study;European Journal of Surgical Oncology;2024-09

2. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy;JAMA Oncology;2024-06-01

3. Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement;British Journal of Surgery;2024-03

4. Current bi‐national attitudes towards targeted axillary dissection;ANZ Journal of Surgery;2023-12-27

5. Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study;Breast Cancer Research and Treatment;2023-12-22